Replies to post #573449 on NorthWest Biotherapeutics Inc (NWBO)

[Astavakra]

I just want to throw something in, though it may have been suggested in previous posts. It's my understanding that NWBO can approach each MM separately, meaning NWBO might settle with some of the lesser MMs and go through to discovery and potentially trial with the larger. If they did go this route, they could glean some cash in the shorter term and wait for the big payday down the road. It's in discovery that things will really start to get interesting. To project a settlement price from the current vantage point is folly, IMHO.

[Doc logic]

skitahoe,

Think about it this way. What is it that investors were expecting to have happen on May 10th with news of a positive trial outcome? The price typically rises to a point somewhere between a high and a low just prior to when a news release event is considered binary right? Ok, if we can agree on that then good news typically would take the price to double or more and a 150% gain is even fairly typical. The equivalent in the opposite direction comes in at a 75% loss. That would have been around $5. Instead the price was dropped to the last remaining uptrend line at about $.385 and bounced up off of that to right about a 75% loss. That “correction” was created by turning “good news into bad” AGAIN by fabrications about the importance of PFS and spoofing/shorting designed to take out stop losses and get non professional investors to panic sell creating even more momentum.
I stated once before that I believed that the damages should conservatively be noted (a good case could be made) to be about $5,000,000,000. Depending on what jurors might think the May 10th news should have been worth it could be more than that which you allude to. Citadel’s big profits from last year might be seen in a whole new light by jurors once discovery occurs. Best wishes.